tailieunhanh - Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways

High levels of thymidine kinase 1 (TK1) and thymidine phosphorylase (TYMP) are key molecular targets by thymidine therapeutics in cancer treatment. The dual roles of TYMP as a tumor growth factor and a key activation enzyme of anticancer metabolites resulted in a mixed outcome in cancer patients. In this study, we investigated the roles of TK1 and TYMP on a thymidine quinoxaline conjugate to evaluate an alternative to circumvent the contradictive role of TYMP. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN